Group One Trading’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $681 | Buy |
214
+100
| +88% | +$392 | ﹤0.01% | 7278 |
|
|
2025
Q4 | $490 | Buy |
114
+100
| +714% | +$896 | ﹤0.01% | 7813 |
|
|
2025
Q3 | $546 | Hold |
14
| – | – | ﹤0.01% | 8139 |
|
|
2025
Q2 | $327 | Hold |
14
| – | – | ﹤0.01% | 7700 |
|
|
2025
Q1 | $218 | Sell |
14
-4
| -22% | -$60 | ﹤0.01% | 7369 |
|
|
2024
Q4 | $330 | Sell |
18
-6
| -25% | -$65 | ﹤0.01% | 7037 |
|
|
2024
Q3 | $261 | Sell |
24
-942
| -98% | -$11K | ﹤0.01% | 6440 |
|
|
2024
Q2 | $8.97K | Sell |
966
-144
| -13% | -$3.44K | ﹤0.01% | 5684 |
|
|
2024
Q1 | $36.4K | Buy |
1,110
+1
| +0.1% | +$26 | ﹤0.01% | 4971 |
|
|
2023
Q4 | $29.7K | Sell |
1,109
-236
| -18% | -$9.77K | ﹤0.01% | 5454 |
|
|
2023
Q3 | $81.4K | Sell |
1,345
-691
| -34% | -$64.8K | ﹤0.01% | 4644 |
|
|
2023
Q2 | $207K | Buy |
2,036
+664
| +48% | +$91.5K | ﹤0.01% | 3890 |
|
|
2023
Q1 | $243K | Sell |
1,372
-636
| -32% | -$213K | ﹤0.01% | 3486 |
|
|
2022
Q4 | $776K | Buy |
2,008
+541
| +37% | +$205K | ﹤0.01% | 2637 |
|
|
2022
Q3 | $494K | Sell |
1,467
-420
| -22% | -$152K | ﹤0.01% | 3248 |
|
|
2022
Q2 | $620K | Buy |
1,887
+681
| +56% | +$239K | ﹤0.01% | 3227 |
|
|
2022
Q1 | $527K | Buy |
1,206
+325
| +37% | +$133K | ﹤0.01% | 3761 |
|
|
2021
Q4 | $386K | Buy |
+881
| New | +$443K | ﹤0.01% | 4409 |
|
|
2021
Q3 | – | Sell |
-493
| Closed | -$247K | – | 8905 |
|
|
2021
Q2 | $253K | Sell |
493
-326
| -40% | -$207K | ﹤0.01% | 4974 |
|
|
2021
Q1 | $640K | Sell |
819
-402
| -33% | -$275K | ﹤0.01% | 3749 |
|
|
2020
Q4 | $665K | Sell |
1,221
-6
| -0.5% | -$3.15K | ﹤0.01% | 3029 |
|
|
2020
Q3 | $562K | Sell |
1,227
-202
| -14% | -$117K | ﹤0.01% | 2740 |
|
|
2020
Q2 | $880K | Buy |
1,429
+30
| +2% | +$16.6K | ﹤0.01% | 2148 |
|
|
2020
Q1 | $665K | Sell |
1,399
-1,662
| -54% | -$903K | 0.01% | 1843 |
|
|
2019
Q4 | $1.77M | Buy |
3,061
+2,277
| +290% | +$1.6M | 0.01% | 1383 |
|
|
2019
Q3 | $516K | Sell |
784
-760
| -49% | -$632K | ﹤0.01% | 2300 |
|
|
2019
Q2 | $1.2M | Buy |
1,544
+833
| +117% | +$585K | 0.01% | 1479 |
|
|
2019
Q1 | $502K | Buy |
711
+71
| +11% | +$42.5K | 0.01% | 1934 |
|
|
2018
Q4 | $300K | Buy |
+640
| New | +$413K | ﹤0.01% | 2367 |
|
|
2018
Q2 | – | Sell |
-197
| Closed | -$100K | – | 5553 |
|
|
2018
Q1 | $88K | Buy |
+197
| New | +$95.6K | ﹤0.01% | 3327 |
|
|
2016
Q2 | – | Sell |
-78
| Closed | -$17K | – | 5001 |
|
|
2016
Q1 | $18K | Buy |
+78
| New | +$23.3K | ﹤0.01% | 3801 |
|
|
2015
Q4 | – | Sell |
-63
| Closed | -$34.6K | – | 5169 |
|
|
2015
Q3 | $32K | Sell |
63
-302
| -83% | -$202K | ﹤0.01% | 3805 |
|
|
2015
Q2 | $160K | Buy |
+365
| New | +$141K | ﹤0.01% | 2707 |
|
Other funds holding TVRD
SPC
VCM
AFG
SAM
DWAM
Group One Trading's TVRD Position: Q1 2026 in Review
Group One Trading increased its Tvardi Therapeutics (TVRD) stake by 88% in Q1 2026, buying an estimated $392 and bringing the position to 214 shares worth $681. The position accounts for ﹤0.01% of the portfolio, ranked #7278.
Group One Trading first reported a position in TVRD in Q2 2015 and has held it in 33 quarters since. The position peaked at $1.77M in Q4 2019. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.
- Group One Trading held 214 shares of Tvardi Therapeutics worth $681 as of Q1 2026.
- Group One Trading bought 100 Tvardi Therapeutics shares in Q1 2026, an estimated $392.
- Tvardi Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7278 holding.
- Group One Trading first reported a position in Tvardi Therapeutics in Q2 2015 and has held it in 33 quarters since.
- Group One Trading's Tvardi Therapeutics position peaked at $1.77M in Q4 2019.
- 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.